- The early treatment of type 2 diabetesRichard E Pratley
Florida Hospital Diabetes and Translational Research Institute, Sanford Burnham Medical Research Institute, Orlando, Fla Electronic address
Am J Med 126:S2-9. 2013....
- Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6)R E Pratley
Florida Hospital Sanford Burnham Translational Research Institute for Metabolism and Diabetes, Orlando, FL, USA
Diabetes Obes Metab 15:234-40. 2013..This study compared the efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes inadequately controlled with sulphonylurea ± metformin...
- Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trialRichard E Pratley
Diabetes Institute, Florida Hospital, Orlando, Florida, USA
Diabetes Care 35:1986-93. 2012..To assess the efficacy and safety of switching from sitagliptin to liraglutide in metformin-treated adults with type 2 diabetes...
- Clinical management of elderly patients with type 2 diabetes mellitusRichard E Pratley
Florida Hospital Diabetes Institute, Sanford Burnham Medical Research Institute, Orlando, FL 32804, USA
Postgrad Med 124:133-43. 2012....